Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | THZ1 | 0.001 | 0.64032 | |
| MDA-MB-134-VI | AZD2014 | 0.00316227766017 | 0.91225 | |
| MDA-MB-134-VI | AZD2014 | 0.00316227766017 | 0.91225 | |
| MDA-MB-134-VI | AZD5363 | 10.0 | 0.91225 | |
| MDA-MB-134-VI | AZD6738 | 0.001 | 0.91225 | |
| MDA-MB-134-VI | AZD6738 | 1.0 | 0.91225 | |
| MDA-MB-134-VI | BMS-265246 | 0.01 | 0.91225 | |
| MDA-MB-134-VI | BMS-265246 | 0.0316227766017 | 0.91225 | |
| MDA-MB-134-VI | BMS-265246 | 0.1 | 0.91225 | |
| MDA-MB-134-VI | BMS-265246 | 3.16227766017 | 0.91225 | |
| MDA-MB-134-VI | Ulixertinib | 0.003162278 | 0.91225 | |
| MDA-MB-134-VI | Ulixertinib | 1.0 | 0.91225 | |
| MDA-MB-134-VI | Alvocidib | 0.316227766017 | 0.91225 |